Qatar Biobank is set to host the nation’s first conference that will explore the development of Qatar’s healthcare and medical research community this month.
Qatar Biobank’s inaugural conference entitled ‘Biobanking in the Context of Personalised Healthcare’ will gather local, regional and international experts to discuss the future of personalized healthcare in integration with Biobanking worldwide. It will be held on the 8 and 9 February at Qatar National Convention Centre (QNCC) in Doha.
Through its collection of samples and information on the health and lifestyles of large numbers of the national population, Qatar Biobank is making vital medical research possible for scientists in Qatar, the region, and the world.
The event, a first of its kind in Qatar, will feature in-depth sessions about the importance of biobanking and its role in improving healthcare services.
Dr Hadi Abderrahim, Managing Director of Qatar Biobank said, “In personalized medicine, therapies are selected for the individual patient based on the levels of different biomarkers contained in the blood and tissues. That is why biobanks play a vital role in personalized medicine, as they provide the bio-specimens required for research to identify such biomarkers.”
A number of keynote speakers will attend the upcoming conference including Edward Abrahams, President of the Personalized Medicine Coalition in the USA; Ma’n H Zawati, Professor at the Center of Genomics and Policy at McGill University in Canada; Elio Riboli, Director of the School of Public Health at Imperial College London; and Dr Hilal Lashuel, Executive Director of QBRI, among others.
For the full story, please click here